Parallax Volatility Advisers’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Parallax Volatility Advisers’s Portfolio IHE Stock Details IHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-3	Closed	–	–	2856
2019 Q2	$0	Hold	3	–	–	﹤0.01%	3118
2019 Q1	$0	Hold	3	–	–	﹤0.01%	3350
2018 Q4	$0	Hold	3	–	–	﹤0.01%	3385
2018 Q3	$0	Hold	3	–	–	﹤0.01%	3051
2018 Q2	$0	Hold	3	–	–	﹤0.01%	2678
2018 Q1	$0	Hold	3	–	–	﹤0.01%	3189
2017 Q4	$0	Hold	3	–	–	﹤0.01%	4407
2017 Q3	$0	Hold	3	–	–	﹤0.01%	2629
2017 Q2	$0	Hold	3	–	–	﹤0.01%	3038
2017 Q1	$0	Hold	3	–	–	﹤0.01%	4069
2016 Q4	$0	Hold	3	–	–	﹤0.01%	3557
2016 Q3	$0	Hold	3	–	–	﹤0.01%	3365
2016 Q2	$0	Hold	3	–	–	﹤0.01%	2983
2016 Q1	$0	Hold	3	–	–	﹤0.01%	3054
2015 Q4	$0	Hold	3	–	–	﹤0.01%	3352
2015 Q3	$0	Hold	3	–	–	﹤0.01%	3448
2015 Q2	$0	Hold	3	–	–	﹤0.01%	4206
2015 Q1	$0	Hold	3	–	–	﹤0.01%	4885
2014 Q4	$0	Buy	+3	New	+$146	﹤0.01%	5411

Other funds holding IHE

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

RCYC

Richard C. Young & Co Newport, Rhode Island $1.21B AUM 38.41% 1-Year Est. Return

MCM

Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

SCP

Syntal Capital Partners Midland, Texas $10M AUM 35.51% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Parallax Volatility Advisers's IHE Position: Q3 2019 in Review

Parallax Volatility Advisers sold out of iShares US Pharmaceuticals ETF (IHE) in Q3 2019, closing a stake of 3 shares.

Parallax Volatility Advisers first reported a position in IHE in Q4 2014 and held it in 19 quarters. The position peaked at $0 in Q2 2019. 82 funds tracked by Wall St. Rank hold IHE as of Q3 2019.

Parallax Volatility Advisers reported no remaining iShares US Pharmaceuticals ETF position as of Q3 2019 after selling out during the quarter.
Parallax Volatility Advisers sold 3 iShares US Pharmaceuticals ETF shares in Q3 2019.
Parallax Volatility Advisers first reported a position in iShares US Pharmaceuticals ETF in Q4 2014 and held it in 19 quarters.
Parallax Volatility Advisers's iShares US Pharmaceuticals ETF position peaked at $0 in Q2 2019.
82 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q3 2019.

Based on Parallax Volatility Advisers's 13F filing for Q3 2019, filed 14 Nov 2019.